Increased LCAT activity and hyperglycaemia decrease the antioxidative functionality of HDL

被引:63
作者
Kappelle, Paul J. W. H. [2 ]
de Boer, Jan Freark [1 ]
Perton, Frank G. [3 ]
Annema, Wijtske [1 ,4 ]
de Vries, Rindert [2 ]
Dullaart, Robin P. F. [2 ]
Tietge, Uwe J. F. [1 ,4 ]
机构
[1] Univ Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands
[2] Univ Groningen, Dept Endocrinol, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands
[3] Univ Groningen, Lab Ctr, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands
[4] TI Food & Nutr, Wageningen, Netherlands
关键词
Cholesterol glucose; HDL; HDL function; lipoproteins; type 2 diabetes mellitus; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; HIGH-DENSITY-LIPOPROTEIN; TYPE-2; DIABETES-MELLITUS; DIET-INDUCED ATHEROSCLEROSIS; APOLIPOPROTEIN-A-I; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; DEFICIENCY SYNDROMES; THERAPEUTIC TARGET; MICE;
D O I
10.1111/j.1365-2362.2011.02604.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Type 2 diabetes mellitus increases the risk of atherosclerotic cardiovascular disease. Antioxidative properties of high density lipoprotein (HDL) are important for atheroprotection. This study investigated whether the antioxidative functionality of HDL is altered in type 2 diabetes mellitus and aimed to identify potential determinants of this parameter. Materials and methods In a cross-sectional study, we investigated 74 patients with type 2 diabetes and 75 control subjects. Antioxidative properties of HDL were measured and expressed as either (i) HDL antioxidative capacity or (ii) HDL antioxidation index after multiplying HDL antioxidative capacity results with individual plasma HDL cholesterol concentrations. Lecithin:cholesterol acyltransferase (LCAT) and paraoxonase-1 (PON-1) activities were determined. Results HDL antioxidative capacity was similar in patients with diabetes and controls, while the HDL antioxidation index was decreased in patients with diabetes (P = 0.005) owing to lower plasma HDL cholesterol (P < 0.001). LCAT activity was higher and PON-1 activity lower in type 2 diabetes mellitus (each P < 0.001). In the combined subjects, HDL antioxidative capacity was inversely related to LCAT activity (P < 0.01). The HDL antioxidation index correlated negatively with blood glucose (P < 0.001), HbA1c and LCAT activity (each P < 0.01), and positively with PON-1 activity (P < 0.01). Multiple linear regression analysis demonstrated that high LCAT activity was associated with both decreased HDL antioxidation capacity (P < 0.05) and index (P < 0.001) independent of diabetes status, glycaemic control and PON-1. Conclusions Overall, the antioxidative functionality of HDL is impaired in type 2 diabetes mellitus mostly because of lower HDL cholesterol. Hyperglycaemia, increased LCAT activity and lower PON-1 activity likely contribute to impaired antioxidative functionality of HDL.
引用
收藏
页码:487 / 495
页数:9
相关论文
共 45 条
[1]  
ALBERS JJ, 1981, J LIPID RES, V22, P1206
[2]  
[Anonymous], 2006, Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: Report of a WHO/IDF consultation
[3]   The paradox of dysfunctional high-density lipoprotein [J].
Ansell, Benjamin J. ;
Fonarow, Gregg C. ;
Fogelman, Alan M. .
CURRENT OPINION IN LIPIDOLOGY, 2007, 18 (04) :427-434
[4]   HDL cholesterol and protective factors in atherosclerosis [J].
Assmann, G ;
Gotto, AM .
CIRCULATION, 2004, 109 (23) :8-14
[5]   Diabetes and atherosclerosis - Epidemiology, pathophysiology, and management [J].
Beckman, JA ;
Creager, MA ;
Libby, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (19) :2570-2581
[6]   High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase [J].
Berard, AM ;
Foger, B ;
Remaley, A ;
Shamburek, R ;
Vaisman, BL ;
Talley, G ;
Paigen, B ;
Hoyt, RF ;
Marcovina, S ;
Brewer, HB ;
SantamarinaFojo, S .
NATURE MEDICINE, 1997, 3 (07) :744-749
[7]   Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin : cholesterol acyltransferase and lipid transfer proteins [J].
Borggreve, SE ;
de Vries, R ;
Dullaart, RPF .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 (12) :1051-1069
[8]  
Brousseau ME, 1997, J LIPID RES, V38, P2537
[9]   The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes -: A comprehensive study of molecular and biochemical findings in 13 unrelated Italian families [J].
Calabresi, L ;
Pisciotta, L ;
Costantin, A ;
Frigerio, I ;
Eberini, I ;
Alessandrini, P ;
Arca, M ;
Bon, GB ;
Boscutti, G ;
Busnach, G ;
Frascà, G ;
Gesualdo, L ;
Gigante, M ;
Lupattelli, G ;
Montali, A ;
Pizzolitto, S ;
Rabbone, I ;
Rolleri, M ;
Ruotolo, G ;
Sampietro, T ;
Sessa, A ;
Vaudo, G ;
Cantafora, A ;
Veglia, F ;
Calandra, S ;
Bertolini, S ;
Franceschini, G .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (09) :1972-1978
[10]   Functional Lecithin: Cholesterol Acyltransferase Is Not Required for Efficient Atheroprotection in Humans [J].
Calabresi, Laura ;
Baldassarre, Damiano ;
Castelnuovo, Samuela ;
Conca, Paola ;
Bocchi, Letizia ;
Candini, Chiara ;
Frigerio, Beatrice ;
Amato, Mauro ;
Sirtori, Cesare R. ;
Alessandrini, Paola ;
Arca, Marcello ;
Boscutti, Giuliano ;
Cattin, Luigi ;
Gesualdo, Loreto ;
Sampietro, Tiziana ;
Vaudo, Gaetano ;
Veglia, Fabrizio ;
Calandra, Sebastiano ;
Franceschini, Guido .
CIRCULATION, 2009, 120 (07) :628-635